Abstract:The epigenetic memory stored in the dynamic modifications, such as base modifications of cytosine (C) in DNA, including methylation/hydroxymethylation/demethylation, causes heritable phenotypes via regulating gene expression without alteration of DNA sequence. The process from cytosine modification to the epigenetic effect is orchestrated by complicated machinery consisting of writers, erasers, readers, and other factors. The two major forms of cytosine modification include methylcytosine (5-mC) and hydroxymethylcytosine (5-hmC). DNA methyltransferases (DNMTs) including DNMT1, DNMT3A, and DNMT3B function as writers for 5-mC. The ten-eleven translocation proteins (TET) including TET1, TET2, and TET3 in the mammalian genome are responsible for hydroxymethylation of 5-mC to generate 5-hmC, 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC). The 5-mC and 5-hmC have become the two most extensively investigated epigenetic markers, and the dynamic balance of these two markers shape the landscape of the epigenome, functioning as a platform to regulate gene expression epigenetically. The landscape of the 5-hmC in epigenome is precisely and tightly regulated during the development. Aberrant alterations of the epigenetic regulation may cause severe consequences such as phenotype change as well as initiation of disease. Progressively, significant achievements have been made in characterization of writers, erasers, and readers of 5-mC and 5-hmC, as well as the contribution of aberrant alteration of 5-hmC/5-mC landscape to the pathogenesis of human diseases, such as cancers and neurological disorders. This article will highlight the research advances in the distinct contribution of TET proteins as suppressors or promoters to the pathogenesis of tumorigenesis and progression. Furthermore, this article also discusses the challenges and the directions for research in the future.

TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease

Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX

TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer

Mechanism and Function of Oxidative Reversal of DNA and RNA Methylation

Role of Tet2 in Regulating Adaptive and Innate Immunity

Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies

TET (Ten-eleven translocation) family proteins: structure, biological functions and applications

Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?

Role of TET enzymes in DNA methylation, development, and cancer

TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair

Tet2 Activity is Modulated by Sirt1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome

The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development

Ten-Eleven-Translocation Genes in Cancer.

Cytosine Modifications and Distinct Functions of TET1 on Tumorigenesis

Insights into the Biochemistry, Evolution, and Biotechnological Applications of the Ten-Eleven Translocation (TET) Enzymes

Structure and Function of TET Enzymes

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review

Role of TET Dioxygenases in the Regulation of Both Normal and Pathological Hematopoiesis

Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis

Multiple Functions of Ten-eleven Translocation 1 During Tumorigenesis.